CD4 and neoplasm: Tumor-specific upregulation of cytokines produced by Th17 CD4+ cells, such as IL-17A and IL-22, has been observed in human CRC [21–23], and studies in mouse models of spontaneous intestinal tumorigenesis have demonstrated the importance of these cytokines in tumor progression [24, 25].